Strengthens focus of Johnson & Johnson as an innovation powerhouse and accelerates the portfolio shift of its MedTech Segment to higher-growth and higher-margin markets Standalone orthopaedics business would operate as DePuy Synthes and be the largest, most comprehensive orthopaedics-focused company in the world Namal Nawana appointed to serve as Worldwide President of DePuy Synthes NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (the "Company†) (NYSE: JNJ) today announced the Company's intent to ...